SK Bioscience appoints former BMS lead Pa-leun Kim as VP
By Eo, Yun-Ho | translator Alice Kang
22.02.03 06:00:28
°¡³ª´Ù¶ó
0
Has accumulated experience in external affairs after working at the Office of the Presidential Secretary for Public Affairs at Cheong Wa Dae
The company is driving capability building initiatives in its R&D department among others after Jae-yong Ahn was appointed CEO
¡ãVP Pa-leun Kim
SK Bioscience is making continued efforts to strengthen the company¡¯s capability by recruiting talents to make the leap forward and become a global vaccine company. According to industry sources, SK Bioscience appointed Pa-leun Kim (44), former Lead at Bristol-Myers Squibb Korea, as its Vice President of Communication and Government Affairs.
The company had been stepping up efforts to develop its COVID-19 vaccine while expanding its CMO business with the appointment of CEO Jae-Yong Ahn (54) in April last year.
In addition to expanding its manufacturing facilities, the company has also been recruiting new talent in various areas since last year. The company's R&D person
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)